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1. Introduction 
The term systemic vasculitis encompasses a group of diseases that were considered rare 
years ago. However, as knowledge of them has been expanded, there have become 
increasingly important in the differential diagnosis of patients with varied manifestations, 
not only rheumatological, but also with sensory and visceral affectation in diverse locations, 
extent and severity.  
This is a heterogeneous group of diseases that often overlap each other, with various 
etiologies and clinical manifestations. The common feature among them is the inflammation 
of the lining of blood vessels, which causes ischemic events and tissue necrosis, as well as 
the occlusion of the lumen of vessels and, consequently, impaired function of the affected 
organ [1]. 
Any blood vessel can be affected by the vasculitic phenomenon. Moreover, the extent and 
site of affectation of the vessels varies depending on the type of vasculitis; in general, they 
tend to be irregular and segmental. In severe forms, lesions spread throughout the body. In 
mild forms, it can be located in a single region of the body; for example, limited to the skin 
in patients with cutaneous leukocytoclastic vasculitis. Others, however, cause lesions in 
several distant organs such as kidneys or lungs in patients with microscopic polyangiitis 
and Wegener’s granulomatosis. Some types of vasculitis manifest with lesions in the same 
stage of development, as in the case of cutaneous lesions that appear with an outbreak of 
Henoch- Schönlein purpura. In others, such as polyarteritis nodosa, lesions that are at 
different stages of development in different organs. Some forms of vasculitis may have an 
acute course, mainly those with a predominantly skin involvement. In contrast, others such 
as Takayasu’s arteritis have shown varying degrees of activity for over 20 years [1]. 
2. Audiovestibular manifestations in systemic vasculitis 
The inner ear may be involved in organ-specific autoimmune diseases such as the 
autoimmune inner ear disease described by McCabe in 1979 and it may be the target organ 
in various non-organ specific systemic diseases. Among these, some are the result of direct 
autoimmune lesion and others of vascular damage which, in turn, can be primary or 
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secondary to infections or collagen diseases. The systemic vasculitis forms belong to the 
group of diseases that have vascular damage as the main pathogenic factor [2, 3]. 
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BPPV: benign paroxysmal positional vertigo; HSC: horizontal semicircular canal; PSC: posterior 
semicircular canal; PAN: panarteritis nudosa; CTSIB: Clinical Test for Sensory Interaction and Balance. 
Table 1. Audiovestibular manifestations in systemic vasculitis 
Interestingly, regardless of the etiology of the various diseases affecting the inner ear, 
pathological findings are identical. They include degeneration and destruction of the 
peripheral receptor; segmental and diffuse infiltration of lymphocytes, plasma cells, and 
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macrophages; proliferation of fibrous tissue, and varying degrees of ossification of the inner 
ear [4]. 
Next, we discuss the studies to date that have disclosed an association of vasculitis 
involvement with auditory and vestibular manifestations. Table 1 presents an update of the 
different audiovestibular manifestations described according to the classification of 
vasculitis. 
3. Primary vasculitis 
Giant cell arteritis (GCA) is a multisystemic vasculitis of elderly people. It mainly involves 
large and medium-sized blood vessels with predisposition to the cranial arteries. GCA 
constitutes the most common systemic vasculitis in Western countries. Some cranial 
ischemic manifestations, in particular permanent visual loss, have been widely described in 
patients with this vasculitis. However, audiovestibular manifestations in GCA patients, such 
as hearing loss, vertigo, or tinnitus, have been less commonly reported. It is also 
characterized by granulomatous affectation of the aorta and its major branches, with a 
predisposition towards the cranial area, both in the arterial branches arising from the 
external carotid (explaining the topical headaches) and the internal carotid artery, leading to 
the feared blindness, either by affectation of the posterior ciliary arteries or the central 
retinal artery. GCA is often present with temporoparietal pulsating headaches, different 
from the usual, which often accompanied by polymyalgia rheumatica and, to a lesser extent, 
jaw claudication, amaurosis fugax, blindness, or stroke predominantly in the vertebrobasilar 
territory [5-8]. The definitive diagnosis is obtained by a temporal artery biopsy 
demonstrating disruption of the internal elastic lamina with lymphocytic inflammatory 
infiltration and multinucleated giant cells in 50% of cases [9].  
The last 4 decades have witnessed a significant increase in the number of diagnosed cases of 
GCA. This increase has not only been found in areas where GCA is common [10] but also 
here the incidence was low [11-13]. This fact can be explained by a greater awareness of the 
disease. In our population in Lugo of individuals older than 50, the incidence of GCA 
adjusted for age and gender is 10/100 000 inhabitants/year, but it reaches 23/100 000 
inhabitants/year in the group of patients between 70 and 79 [14,15]. 
In a prospective study of 44 patients with GCA and 10 with isolated polymyalgia 
rheumatica from our Lugo population, in 39 (89%) of the 44 GCA patients only exhibited 
abnormalities in the vestibular tests when these were performed in the first four days at the 
onset of diagnosis and parenterally corticosteroid therapy. Our data suggest that the 
vestibule is very sensitive to the ischemic effects of the GCA. Also, they suggest that the 
vestibular damage may be reversible in some cases. With respect to this, only 13 (30%) of the 
44 after 3 months of treatment and 1 patient after 6 months of follow-up had persistent 
vestibular impairment, coinciding with the start of treatment with steroids. The most 
significant vestibular finding observed at 3 months was paretic horizontal nystagmus in the 
head shaking nystagmus test. Moreover, although in our study a Dix-Hallpike test was 
found to be positive in 7% of the control population, this test yielded positive results in 21% 
of the biopsy-negative GCA and 33% of biopsy-positive GCA patients. This finding in GCA 
patients seems to be extremely high. It may suggest that in some cases the benign 
paroxysmal positional vertigo (BPPV) may be related to a vasculitic inflammatory disorder. 
Furthermore, we found a close relationship between GCA and benign paroxysmal positional 
vertigo of the posterior semicircular canal in our population [16,17]. 
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In our series, the audiometric tests at the time of diagnosis showed a remarkable auditory 
dysfunction in GCA patients. Another point to be considered from our study was the 
presence of a frequent asymmetrical auditory dysfunction that it is in keeping with the 
asymmetrical cranial manifestations reported in many patients with GCA. During follow-up 
improvement in auditory function was observed within the first 3 months after the onset of 
therapy. However, such an improvement was only found  in 27% of the cases. In addition, 
despite corticosteroid therapy, further deterioration in auditory function after 3 months of 
treatment was detected in 3 patients. Moreover, no additional improvement in hearing 
function was observed after another 3 months of treatment. These data suggest that the 
possible improvement in hearing function may be achieved generally early during the first 
months after the onset of therapy [16]. In summary, our results support the presence of both 
auditory and vestibular dysfunction closely related to the vasculitic process in GCA 
patients. 
Polymyalgia rheumatica is characterized by pain in the scapulae and proximal aspects of 
the shoulders, pelvis and proximal aspects of the lower extremities and the cervical region, 
together with morning stiffness of more than 1 h; it may be present in about 40% of patients 
with GCA [5]. However, polymyalgia rheumatica may be a separate entity [6] or the initial 
form of a GCA that does not initially show cranial condition data or other ischemic 
symptoms suggesting a GCA [18]. Therefore, the presence of audiovestibular abnormalities 
in one of our patients who initially showed only clinical symptoms of polymyalgia 
rheumatica was of particular importance. The patient did not initially present the ischemic 
vascular disease typical of GCA, but at follow-up showed the typical manifestations 
attributable to it. The presence of vestibular dysfunction may be an alarm sign to consider 
the possibility of having a "silent and subclinical" GCA in those patients presenting with 
PMR symptoms. In this regard, the presence of vestibular dysfunction, probably related to 
ischemic manifestations, may be considered as an early and reversible sign in the course of 
the disease. Thus, the knowledge of these manifestations as alert signs for a possible 
underlying GCA is of main importance in elderly people as early corticosteroid treatment 
reduces significantly the risk of blindness due to GCA. This fact is even more important in 
GCA whose presenting manifestation is PMR only, as in these cases low dose prednisone 
does not prevent the development of blindness. The presence of abnormal vestibular tests in 
patients presenting with PMR without cranial manifestations of GCA may be considered as 
a red flag to raise the suspicion of an underlying GCA [16].  
Takayasu’s arteritis is a chronic vasculitis of unknown etiology that affects the aorta, its 
major branches, the pulmonary artery and the coronary arteries; it causes headache, absence 
of arterial pulses, heart failure, renovascular hypertension and ocular and cerebral ischemia. 
In contrast to GCA, Takayasu’s arteritis primarily affects young people, especially women 
between 15 and 25, more commonly in Asian or Central-American populations [19]. In this 
vasculitis affecting large vessels, a patient has been described who presented sudden 
deafness and decreased pulse in the radial artery. The hearing condition worsened upon 
withdrawal of parenterally administered steroids and improved when they were 
reintroduced [20]. Histopathological studies of the temporal bone are of great interest in 
patients with systemic vasculitis. Among them, those published for patients diagnosed with 
polyarteritis nodosa (PAN) should be highlighted. In a patient whose first manifestation of 
the disease was sudden unilateral deafness and vertigo, the temporal bone histopathological 
study showed bilateral cochlear condition in the form of loss of the organ of Corti in various 
portions of the cochlea, the absence of the tectorial membrane and atrophy of the stria 
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vascularis, whereas no vestibular histopathological changes were observed [21]. In another 
patient with a diagnosis of PAN and unilateral profound hearing loss and vertigo, the 
histopathological study found vasculitis in the internal auditory artery, accompanied by 
ossification of the cochlea and the vestibular system as well as endolymphatic hydrops in 
the basal ramp of the cochlea [22]. The loss of sensory cells and neurons in the maculae of 
the semicircular canals, utricle and saccule has also been reported in PAN [23]. Most of the 
reported cases with a diagnosis of PAN met the criteria of the Chapel Hill Consensus 
Conference relative to microscopic polyangiitis. Recently, the possibility has been described 
of obtaining a recovery of hearing through a cochlear implant in a patient diagnosed with 
PAN by biopsy. This reinforces the impression that the lesion is located at the cochlear level. 
In this group of patients with PAN and profound bilateral hearing loss, this may be 
secondary to labyrinthine ischemia by a vascular phenomenon [24]. 
Kawasaki disease (KD) is a diffuse necrotizing vasculitis involving medium-sized vessels, 
with almost constant injury of the coronary arteries and large non-intraparenchymatous 
arteries. 85% of patients with KD are children under 5 in whom the disease occurs 
sporadically or in small outbreaks. It is predominant in males (1.5:1) and, although it is more 
frequent in Japan, the disease has been diagnosed in more than 40 countries [25].  In a study 
of 62 patients diagnosed with KD, sensorineural hearing loss was described in the acute 
phase of the disease in 30% and conductive hearing loss in 9%. On examination of auditory 
function after the acute phase, neurosensorial hearing loss persisted in 5.5% of patients, so 
the partially reversible character after treatment with steroids was confirmed [26].  
Wegener’s granulomatosis is defined as a granulomatous inflammation that affects the 
airways combined with necrotizing vasculitis of small and medium vessels together with 
glomerulonephritis and positive cANCA [27]. Furthermore to the known hearing loss 
secondary to obstruction of the Eustachian tube due to granulomas in the nasopharynx, a 
series of 21 patients described sudden hearing loss and tinnitus [28]. Bilateral sensorineural 
hearing loss was observed in 12 of 13 patients with auditory symptoms in a series of 19 
patients diagnosed with Wegener’s disease by biopsy [29]. Some patients also described 
vestibular manifestations such as vertigo and peripheral nystagmus [30]. 
Churg-Strauss allergic granulomatous vasculitis is characterized by granulomas in the 
upper airways, with eosinophilic infiltration and systemic vasculitis in medium and small 
vessels, along with a history of asthma, circulating eosinophilia and high concentrations of 
circulating IgE [27]. It has been described with otitis media with effusion, acute otitis media 
and progressive sensorineural hearing loss in 9.5% of patients, who improved or stabilized 
after administration of steroids and immunosuppressors [31]. 
Behcet’s disease is a multisystemic, chronic and recurrent disease that almost always occurs 
with oral thrush and, in variable frequency, genital sores, uveitis, skin lesions and 
neurological, vascular and gastrointestinal manifestations with a pathological substrate of 
leukocytoclastic or lymphocytic vasculitis, preferably from capillaries and venules [32]. 
Auditory manifestations such as sudden deafness have been described, as well as vertigo 
during the course of the disease and in relapses [33,34].  Sensorineural hearing loss with a 
cochlear location was described in 30% of 62 patients diagnosed with Behcet’s disease, and 
central vestibular syndrome in 40% [35].  
Cogan’s syndrome is characterized by fluctuating hearing loss, tinnitus, spontaneous 
sudden vertigo, and interstitial keratitis. A significant audiovestibular function has also 
been described. However, the reported damage is so severe that it does not seem to be the 
result of a true vasculitis, but rather of a primary labyrinthitis [36].  
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4. Secondary vasculitis 
Rheumatoid arthritis is a chronic, multisystemic inflammatory disease characterised by 
persistent inflammatory synovitis, usually involving peripheral joints in a symmetrical 
manner, predominantly the wrists, the metacarpophalangeal and proximal interphalangeal 
joints of the hands, elbows and knees and metatarsal-phalangeal of feet. It is more common 
in women; although its etiology is unknown, there is a genetic predisposition, as shown by 
the tendency to familial aggregation, the high concordance with rheumatoid arthritis in 
monozygotic twins and the association with genes within the major histocompatibility 
complex, particularly with certain alleles that share a common sequence of amino acids 
within the hypervariable control region of the HLA-DRB1 chain, called shared epitope [37]. 
One study has described sudden hearing loss in patients with RA with an underlying 
vasculitic process affecting the eighth cranial nerve [38]. 
In the Lugo population, as in the Anglo-Saxon, an association of rheumatoid arthritis with 
HLA-DR4 alleles has been observed, in particular with HLA-DRB1*0401 and *0404. These 
alleles have also been shown as markers of vascular damage in patients with rheumatoid 
arthritis in Lugo, since patients with these alleles are at increased risk of endothelial vascular 
dysfunction [39] a marker of early stage of atherosclerosis and an increased risk of 
cardiovascular events [40]. 
Interestingly, in a series of 33 patients diagnosed with idiopathic sudden hearing loss in our 
Lugo population, we also observed an association of HLA-DR4 with increased susceptibility 
to the disease and a worse prognosis for recovery with steroid treatment [41]. Accordingly 
with this, an increased susceptibility to sensorineural hearing loss has been described in 
patients with rheumatoid arthritis with respect to a control group. Specifically, in a series of 
194 patients diagnosed with rheumatoid arthritis, sensorineural hearing loss was also 
described in 39% [42]. The coincidence of findings involving HLA-DR4 alleles with 
increased severity of rheumatoid arthritis [37] and its association with increased risk of 
vascular damage in this disease [39,40] together with the finding of an increased risk of 
sudden deafness with worse functional outcome in people presenting HLA-DR4 may 
indicate that these alleles would be true markers of endothelial vascular damage regardless 
of the underlying disease [41]. 
Scleroderma or systemic sclerosis is included in the collagenosis group. Systemic sclerosis 
(SSc) is a disease characterized by excessive deposition of connective tissue and extracellular 
matrix proteins in different organs and tissues, and is more common in women. Its etiology 
is unknown, but it is known to involve disorders of collagen synthesis as well as vascular 
and immune system abnormalities. Two clinical forms have been established: the limited 
and the diffuse variants. The predominate features in the limited form are Raynaud’s 
phenomenon, clinical data defined in the CREST syndrome (calcinosis, Raynaud’s 
phenomenon, sclerodactyly, oesophageal disorders, and telangiectasia), increased risk of 
pulmonary hypertension and presence of positive antinuclear antibodies anticentromere B 
positive and distal skin condition in the extremities [43]. In the diffuse form, the 
predominate features are proximal skin condition and more intense injury to internal organs 
that leads to increased risk of pulmonary fibrosis and renal scleroderma crisis, typically 
associating with anti-SCL70 positive antibodies [43].  
Recently, in the population of Lugo, we tried to assess the presence of audiovestibular 
damage in a homogenous cohort of patients with limited SSc and antibodies against 
CENB. We were able to observe abnormalities of audiometric and vestibular tests 
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supporting the presence of audiovestibular damage in limited forms of SSc. We also 
examined the influence of disease duration on the development of audiovestibular 
abnormalities; however, we found no association between disease duration and the 
development of abnormalities of audiometric, vestibular, or postural tests. Nevertheless, 
we found a significantly increased frequency of patients with abnormal hearing loss in the 
audiogram (77%). Of interest, a high frequency loss in the audiogram was common in our 
series; the typical pattern of hearing impairment in our patients with limited SSc was a 
bilateral and symmetrical sensorineural hearing loss with a flat curve in the audiogram. 
Vasculitis leading to focal strial atrophy or malfunction of the hair cells of the organ of 
Corti, or both, has been proposed as responsible for sensorineural hearing loss in SSc. 
Besides sensorineural damage, we also found middle ear dysfunction, manifested by a 
flattened tracing in tympanometry in 20% of the patients with limited SSc, due to 
myringosclerosis confirmed by otomycroscopic examination.  
Furthermore, our results confirm that the vestibule is also involved in SSc, even in limited 
forms of the disease. Patients with limited SSc had a significantly increased frequency of 
abnormal oculo-cephalic response or head thrust test (29%) and head-shaking nystagmus 
(26%), and a higher frequency of 3 or more abnormal positions when positional nystagmus 
was assessed by means of videonystagmography and videonystagmoscopy goggles [44]. 
The static postural study also yielded a significantly increased frequency of abnormal 
clinical test of sensory interaction and balance (CTSIB) in limited and diffuse SSc patients 
(46%) compared with controls (12%). Interestingly, vestibular loss was the main pattern of 
abnormal CTSIB in our patients. All these findings support the presence of a peripheral 
vestibular lesion, probably due to vascular involvement in patients with SSc. 
In our series, almost a fifth of the patients with limited and diffuse SSc showed a benign 
paroxysmal positioning vertigo (BPPV) that was generally caused by the involvement of the 
horizontal semicircular canal (HSC). Interestingly, we observed the presence of abnormal 
caloric test in 43% of SSc patients with associated BPPV. These observations indicate that 
abnormalities found in our patients with SSc are not the result of an injury in a single 
semicircular canal of the inner ear. They also suggest that vascular disease in the setting of 
this connective tissue disease may be responsible for these findings, supporting an ischemic 
cause as responsible for the functional damage. However, an alternative cause for BPPV 
could be related to a possible intralabyrinthine autoimmune process [45]. 
In summary, we have described hearing and vestibular dysfunctions, as well as an abnormal 
postural control of static balance in systemic sclerosis, both in limited and in diffuse forms. 
The etiology is probably vasculitic, although a direct autoimmune mechanism in the inner 
ear cannot be ruled out. In this patient group studied, we highlight symmetrical and 
bilateral sensorineural hearing loss, vestibular hypofunction on caloric testing and an 
abnormal response in head shaking nystagmus test and oculocephalic maneuver (head 
thrust test), all these findings are typically related with peripheral vestibular dysfunction. 
Furthermore, we also describe a close association with benign paroxysmal positional vertigo 
(BPPV), predominantly of the horizontal canal [44,45].  
Systemic lupus erythematosus (SLE) is the prototype of autoimmune disease, which 
primarily affects women between 15 and 50 and also causes secondary vasculitis [46].  
Sensorineural hearing loss has been observed with relative frequency in this group of 
patients with SLE, and both autoimmune and vasculitic mechanisms have been involved in 
its pathogenesis [47].  
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Hearing loss and vertigo of probable ischemic origin have been described in relapsing 
polychondritis, an autoimmune disease that affects, unilaterally or bilaterally, the cartilage 
of the ear, nose and trachea. Its pathophysiology has been explained assuming the existence 
of a vasculitis of the labyrinthine artery and its branches [48].  
Another disease involving audiovestibular manifestations and vasculitis is Sjögren’s 
syndrome. This is a slowly progressing, chronic auto-immune disease, characterized by 
lymphocytic infiltration of exocrine glands, as well as hyper-reactivity and proliferation of B 
cells that end up producing xerostomia and dry eyes. It may be primary or secondary; in the 
latter case, it is accompanied by another auto-immune disease with systemic clinic, as occurs 
in 30% of patients. It mainly affects women between 40 and 50.  
Like SLE, Sjögren’s syndrome also causes secondary vasculitis [46]. Sensorineural hearing 
loss concomitant with cardiolipinic antibodies has been described in 14 of 30 patients with 
Sjögren’s syndrome [49]. A sudden hearing loss has also been reported as initial and 
exceptional presentation in a case of Sjögren’s syndrome [50].  
Ankylosing spondylitis (AS) is a chronic inflammatory disease of unknown origin affecting 
up to 1% of the population. To further investigate hearing loss in AS we studied a series of 
50 consecutive patients that fulfilled the modified New York diagnostic criteria for AS and 
44 matched controls from the Lugo region of Northwest Spain. In this study, 29 (58%) of the 
patients with AS showed abnormal hearing loss in the audiogram compared to only 8 (18%) 
of the controls. Of interest, the audiogram shape disclosed a predominant pattern of 
symmetrical high frequency sensorineural hearing loss in AS patients (50%). In our study, 
individuals with severe extraspinal manifestations had an increased risk of having 
hypoacusia. Furthermore, the presence of hip involvement, anterior uveitis, and HLA-B27 in 
patients with AS appears to be a signal for sensorineural hearing loss (SNHL) that deserves 
further investigation. Besides sensorineural damage, in our series middle ear dysfunction, 
manifested by an abnormal tympanometry, was found in 8% of patients with a flattened 
tracing who was considered the most specific sign of abnormal tympanometry in AS 
patients. This finding could be explained by an increased rigidity of the tympanossicular 
system. 
Furthermore, our results confirm that the vestibule is also involve in patients with AS. 
Patients with AS have a marginally increased frequency of abnormal head thrust test and a 
significantly increased frequency of abnormal head-shaking nystagmus in oculocephalic 
response study (vestibule-ocular reflex) and disclosed an abnormal vestibular function in 
caloric testing (canal paresis). 
In our series from Lugo, we also founded a significantly increased frequency of abnormal 
CTSIB results in AS patients (36%).  In this regard, increased frequency of abnormal postural 
control in CTSIB test was of vestibular origin, conditions 5 and 6 of the study, that 
correspond to a vestibular pattern of the study in patients with AS.  
All our findings support the presence of a peripheral vestibular lesion in patients with AS. 
On the other hand, although the difference did not reach statistical significance, BPPV also 
was found more frequently in patients than in the controls. Therefore, these studies confirm 
the presence of inner ear compromise and audiovestibular dysfunction in patients with AS 
that may be the result of vascular involvement or due to a direct immune-mediated injury of 
the inner ear and it could provide justification for rheumatologists or physicians to screen 
for inner ear compromise in their AS population. [51,52].  
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5. Role of serological study 
As for serological markers that could help diagnose diseases involving vascular damage, 
some studies suggest an etiopathogenic role of anti-endothelial cell antibodies (AECA). 
These could be regarded as markers of immune-mediated vascular damage in vasculitis, as 
well as sudden hearing loss, where some authors assign it a direct involvement in 
physiopathology [53,54]. However, in our population, we could not confirm the diagnostic 
or pathogenic role of AECA in patients diagnosed with GCA through temporal artery 
biopsy in whom vestibular dysfunction and sensorineural hearing loss had been confirmed 
[55]. 
As far as we know, there is no specific marker to support the diagnosis of immune-mediated 
inner ear disease. We must suspect it based on a combination of a compatible clinic together 
with the findings derived from conducting vestibular, hearing and laboratory tests for each 
disease. 
6. Conclusions 
The vasculitis forms are a heterogeneous group of diseases in which audiovestibular 
symptoms are relatively more common than was initially considered, both at the beginning 
of the vasculitis and in the evolution of the process. Studies confirm that the search for 
changes in auditory and vestibular tests shows both peripheral and central disorders. 
Furthermore, the audiovestibular dysfunction could be explained by an ischemic 
mechanism mediated by the inflammatory vasculitic phenomenon in primary vasculitis, but 
one cannot rule out the role of a direct autoimmune mechanism when the inner ear is 
involved in secondary vasculitis. In our population, BPPV was found more frequently when 
was studied in GCA, SS and AS. Moreover, patients with GCA showed more frequent 
findings of BPPV than SS and this more than AS. This finding may suggest that BPPV could 
be associated with more frequency when vasculitis was the main pathogenic factor 
mediated by ischemia. In SS and AS patients both autoimmune and vasculitic mechanisms 
could be involved in its pathogenesis. 
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